We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized ... PolyPid Ltd is a clinical stage specialty pharmaceutical company engaged in research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the Company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, BonyPid-1000, BonyPid-500, PLEX, and D-PLEX are trademarks of the Company. The Company is subject to extensive regulation by the FDA, under the Federal Food, Drug, and Cosmetic Act, as well as by other federal, state, and local regulatory agencies. Show more
Ask ADVFN Intelligence (AI)
| Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.17 | 5.80204778157 | 2.93 | 3.22 | 2.7023 | 14105 | 3.04173402 | CS |
| 4 | 0.33 | 11.9133574007 | 2.77 | 3.85 | 2.37 | 50786 | 3.00972093 | CS |
| 12 | -0.32 | -9.3567251462 | 3.42 | 3.85 | 2.37 | 26707 | 3.11254085 | CS |
| 26 | -1.02 | -24.7572815534 | 4.12 | 4.42 | 2.37 | 15311 | 3.21340805 | CS |
| 52 | -3.79 | -55.007256894 | 6.89 | 7.29 | 2.37 | 9487 | 3.53165885 | CS |
| 156 | -180.2 | -98.3087834152 | 183.3 | 207 | 2.37 | 144213 | 41.76660801 | CS |
| 260 | -476.9 | -99.3541666667 | 480 | 583.5 | 2.37 | 111760 | 85.084127 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
